NEW YORK - A Ludwig Cancer Research study has identified a key barrier to the efficacy of a promising combination of ...
News-Medical.Net on MSN3d
New drug combination shows promise in treating melanoma brain metastasisA federally funded research team led by Sheri Holmen, PhD, investigator at Huntsman Cancer Institute and professor in the ...
Novel HER2 therapies show strong intracranial efficacy, enabling systemic treatment over local therapy for small, ...
Information on the survival of urothelial cancer (UCa) patients with brain metastases (BM) is largely unreliable due to the rarity of such cases. Previous studies that have attempted to capture the ...
Targeted therapies have significantly improved outcomes for patients with non-small cell lung cancer (NSCLC) with actionable mutations. However, many tumors inevitably develop drug resistance and ...
Despite the high incidence of brain metastasis after resection of non-small cell lung cancer (NSCLC), the National Comprehensive Cancer Network guidelines do not recommend central nervous system (CNS) ...
A phase II trial shows that pembrolizumab and bevacizumab yield a 54.1% intracranial response rate and a median overall ...
2025 — A new study shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed. The study suggests ... Jan. 14, 2025 — Researchers have ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback